FARYDAK
Live / Registered — Registered — Section 71 accepted (as of 23 Jul 2018)
What this means for you
Registered since 16 Sept 2008. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79050673
- Registration number
- 3502071
- Mark type
- Stylized text
- Filed
- 01 Feb 2008
- Published for opposition
- 01 Jul 2008
- Registered
- 16 Sept 2008
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for use in oncology
Owner
- pharma& Schweiz GmbH, CH
- Secura Bio, Inc., US
- Novartis AG, CH
- NOVARTIS AG, CH-4002 Basel, CH
- NOVARTIS AG, CH-4002 Basel, CH
Prosecution history
- 20 Oct 2023 — LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED
- 24 Jul 2023 — RESTRICTION OF HOLDER'S RIGHT OF DISPOSAL RECEIVED
- 19 Feb 2023 — CHANGE OF OWNER RECEIVED FROM IB
- 27 Oct 2020 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 27 Oct 2020 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 27 Oct 2020 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 27 Oct 2020 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 27 Oct 2020 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 08 Aug 2019 — CHANGE OF OWNER RECEIVED FROM IB
- 23 Jul 2018 — NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
- 23 Jul 2018 — REGISTERED-SEC.71 ACCEPTED
- 13 Jul 2018 — TEAS SECTION 71 RECEIVED
- 15 Feb 2018 — INTERNATIONAL REGISTRATION RENEWED
- 16 Sept 2017 — COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
- 15 Mar 2015 — NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED